Blood culture tests help detect microorganisms such as bacteria, yeast, and fungi in the blood. These tests also help identify blood stream infections (BSIs) such as septicemia, a serious and life-threatening complication. These tests guide physicians to offer proper treatment for infections. People are at a higher risk of systemic infections if they have had any recent infection, surgical procedure, prosthetic heart valve replacement, or immunosuppressive therapy. They increase the need for blood culture tests for these people. These tests are also performed in newborns and young children, who may have an infection but show no typical symptoms of sepsis.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by application

Bacteremia

Fungemia

Mycobacteria

PART 07: Market segmentation by technology

Global conventional or manual blood culture market

Global automated blood culture tests market

PART 08: Market segmentation by product

Global blood culture tests market for consumables

Market size and forecast

Global blood culture tests market for instruments

Market size and forecast

PART 09: Market segmentation by end-user

Hospitals

Diagnostic clinical laboratories

Research laboratories and academia

PART 10: Geographical segmentation

Blood culture tests market in Americas

Blood culture tests market in EMEA

Blood culture tests market in APAC

PART 11: Market drivers

High incidence of blood stream and transfusion

infections

Use of automated blood culture systems

Outsourcing samples to private reference laboratories

PART 12: Impact of drivers

PART 13: Market challenges

Lack of specialists for automated PCR techniques in

emerging countries

Stringent regulatory framework

High cost of automated blood testing systems

Unfavorable reimbursement scenario

PART 14: Impact of drivers and challenges

PART 15: Market trends

Demand for rapid diagnostic tests

Advances in IT in automated blood culture method

Demand for DAT and OTC self-tests

PART 16: Vendor landscape

Competitive scenario

PART 17: Major vendors

bioMérieux

BD

Roche Diagnostics

ThermoFisher Scientific

Cepheid

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio